دورية أكاديمية

Thrombotic Complications in Immune Thrombocytopenia Patients Treated with Avatrombopag.

التفاصيل البيبلوغرافية
العنوان: Thrombotic Complications in Immune Thrombocytopenia Patients Treated with Avatrombopag.
المؤلفون: Abdelsamia, Mahmoud, Farid, Saira, Dean, Steven, Cataland, Spero R.
المصدر: Hematology Reports; Sep2023, Vol. 15 Issue 3, p518-523, 6p
مصطلحات موضوعية: IDIOPATHIC thrombocytopenic purpura, AVATROMBOPAG, THROMBOPOIETIN receptor agonists, THROMBOTIC thrombocytopenic purpura, PERIPHERAL vascular diseases, SPLENECTOMY, PULMONARY embolism
الشركة/الكيان: UNITED States. Food & Drug Administration
مستخلص: Avatrombopag is a novel oral non-peptide thrombopoietin receptor agonist (TPO-RA) that was approved by the FDA as a second-line therapy for chronic immune thrombocytopenia (cITP). Avatrombopag has shown promising results in regards to efficacy and tolerability, but to our knowledge, there are no reports of thrombotic complications associated with avatrombopag. We present two patients with chronic ITP who suffered thromboembolic events shortly after starting treatment with avatrombopag. The first case is that of a 30-year-old female with refractory cITP who failed multiple lines of ITP therapy and was hospitalized with an intracranial bleed. The patient eventually recovered after an emergent splenectomy but subsequently developed a right lower lobe pulmonary embolism three weeks after starting treatment with avatrombopag. The second case is that of a 58-year-old female with a prolonged history of ITP, and no prior history of peripheral vascular disease, who suffered from both arterial and venous thrombotic events four weeks after starting avatrombopag. Given the new arterial and venous thrombotic complications, avatrombopag was stopped. She was challenged with avatrombopag again and developed yet another thrombotic complication. [ABSTRACT FROM AUTHOR]
Copyright of Hematology Reports is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:20388322
DOI:10.3390/hematolrep15030054